Drug Index


Mechanism :

Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is phosphorylated to the active metabolite adefovir diphosphate by cellular kinases. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and by causing DNA chain termination after its incorporation into viral DNA.

Indication :

  • Chronic hepatitis B

Contraindications :

Contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the product.

Dosing :

Chronic hepatitis B:
In <12 years: Not recommended.
In ≥12 years: 10 mg/day orally.
Renal impairment:
If CrCL >50 ml/min: No need for dose adjustment.
CrCL 30-49 ml/min: 10 mg orally every 48 hours.
CrCL 10-29 mg/min: 10 mg orally every 72 hours.

Adverse Effect :

Nausea, dyspepsia, headache, asthenia, diarrhea, flatulence, skin rash, hematuria, back pain, renal insufficiency and hypophosphatemia.

Interaction :

Ganciclovir-Valganciclovir: May enhance the adverse/toxic effect of Reverse Transcriptase Inhibitors (Nucleoside). Hematologic toxicity is of specific concern.
Ribavirin: May enhance the hepatotoxic effect of Reverse Transcriptase Inhibitors (Nucleoside). Lactic acidosis may occur.
Tenofovir: Adefovir may diminish the therapeutic effect of Tenofovir. Specifically, adefovir-associated mutations in Hepatitis B viral reverse transcriptase may decrease viral susceptibility to tenofovir. Tenofovir may increase the serum concentration of Adefovir. Similarly, Adefovir may increase the concentration of Tenofovir.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-5010 mg every 48 hours
10-2010 mg every 72 hours
<1010 mg every 72 hours

Dose in Patients undergoing Renal Replacement Therapies
CAPDUnknown dialysability. Dose as in GFR<10 mL/min
HDDialysed. 10 mg weekly or after a cumulative total of 12 hours dialysis.
HDF/High fluxDialysed. Dose as in GFR<10 mL/ min
CAV/VVHDUnknown dialysability. Dose as in GFR=10–20 mL/min

Hepatic Dose :

No dosage adjustments are recommended.
12/24/2023 09:16:18 Adefovir
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0